These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4591390)

  • 1. Estrogen influence on the hypothalamic enzymes involved in the formation of melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF).
    Celis ME; Taleisnik S
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):142-4. PubMed ID: 4591390
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
    Walter R; Griffiths EC; Hooper KC
    Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of a melanocyte-stimulating hormone-release inhibiting factor by hypothalamic extracts from rats.
    Celis ME; Taleisnik S
    Int J Neurosci; 1971 Apr; 1(4):223-30. PubMed ID: 4949884
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone.
    Celis ME; Taleisnik S; Walter R
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1428-33. PubMed ID: 5283931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen on pituitary melanocyte-stimulating-hormone content.
    Taleisnik S; Tomatis ME
    Neuroendocrinology; 1969; 5(1):24-32. PubMed ID: 5353734
    [No Abstract]   [Full Text] [Related]  

  • 6. Time interval between injection of estradiol benzoate and LH release in the rat and effect of actinomycin D or cycloheximide.
    Jackson GL
    Endocrinology; 1973 Oct; 93(4):887-92. PubMed ID: 4580535
    [No Abstract]   [Full Text] [Related]  

  • 7. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM; Redding TW; Kastin AJ; Schally AV
    Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothalamic neurohormones regulating anterior pituitary function.
    Schally AV; Arimura A; Bowers CY; Kastin AJ; Sawano S; Reeding TW
    Recent Prog Horm Res; 1968; 24():497-588. PubMed ID: 4973635
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of actinomycin D on the inhibitory response of estrogen on LH release.
    Schally AV; Bowers CY; Carter WH; Arimura A; Redding TW; Saito M
    Endocrinology; 1969 Aug; 85(2):290-9. PubMed ID: 4891431
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of reserpine on the pituitary content of melanocyte-stimulating hormone and on hypothalamic factors which affect its release.
    Tomatis ME; Taleisnik S
    J Endocrinol; 1968 Dec; 42(4):505-12. PubMed ID: 4886788
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of ovarian steroid feedback upon radioimmunoreactive luteinizing hormone releasing hormone in the hypothalamus.
    Yanaihara T; Arai K; Kanazawa M; Okinaga S; Yanaihara N; Yanaihara C
    Endocrinol Jpn; 1975 Dec; 22(6):525-30. PubMed ID: 782859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A MELANOCYTE-STIMULATING HORMONE-RELEASING FACTOR IN HYPOTHALAMIC EXTRACTS.
    TALEISNIK S; ORIAS R
    Am J Physiol; 1965 Feb; 208():293-6. PubMed ID: 14259963
    [No Abstract]   [Full Text] [Related]  

  • 13. DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).
    Plotnikoff NP; Kastin AJ; Anderson MS; Schally AV
    Life Sci I; 1971 Nov; 10(22):1279-83. PubMed ID: 4947365
    [No Abstract]   [Full Text] [Related]  

  • 14. MSH-release inhibiting factors: recent studies.
    Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
    Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
    [No Abstract]   [Full Text] [Related]  

  • 15. The present concept of the nature of hypothalamic hormones stimulating and inhibiting the release of pituitary hormones.
    Schally AV; Kastin AJ
    Triangle; 1969; 9(1):19-25. PubMed ID: 4980829
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats.
    McPherson JC; Costoff A; Mahesh VB
    Fertil Steril; 1977 Dec; 28(12):1365-70. PubMed ID: 201506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of an in vitro system for estimating oxytocinase in the rabbit hypothalamus and the effects of some protein synthesis inhibitors and oestradiol-17 beta on enzyme activity.
    Frith DA; Hooper KC
    Acta Endocrinol (Copenh); 1974 Mar; 75(3):443-51. PubMed ID: 4405987
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of estrogen and progesterone on the release of MSH in gonadectomized rats.
    Celis ME
    Neuroendocrinology; 1977; 24(2):119-28. PubMed ID: 24814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gonadectomy and reposition of gonadal steroids on alpha-melanocyte-stimulating hormone concentration in discrete hypothalamic areas during a 24-hour period.
    Scimonelli TN; Celis ME
    Neuroendocrinology; 1987 Jun; 45(6):441-5. PubMed ID: 3614548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies of MSH-release-inhibiting hormone.
    Celis ME; Hase S; Walter R
    FEBS Lett; 1972 Nov; 27(2):327-30. PubMed ID: 4352026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.